DENISE MELI: Open Payments
NPI 1053783977 · COATESVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 20 payments from 12 companies in 2025. Trend: 2023 $646 · 2024 $815 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $113 |
| Novo Nordisk Inc | 3 | $67 |
| PFIZER INC. | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $52 |
| ABBVIE INC. | 3 | $48 |
| Sage Therapeutics, LLC | 1 | $36 |
| Astellas Pharma US Inc | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Lundbeck LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: VOQUEZNA, Wegovy, NURTEC ODT, TRELEGY ELLIPTA, VRAYLAR, Veozah, CAPLYTA, REXULTI.
Industry payments across PA — which companies pay providers there.
